Fidelity Investments’s Tempest Therapeutics TPST Stock Holding History

Fidelity Investments’s Portfolio TPST Stock Details TPST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-33,225	Closed	-$54.5K	–	5722
2026 Q1	$54.5K	Hold	33,225	–	–	﹤0.01%	4092
2025 Q4	$95.4K	Sell	33,225 -1	-0%	-$7	﹤0.01%	3774
2025 Q3	$342K	Buy	33,226 +1	+0%	+$9	﹤0.01%	3178
2025 Q2	$226K	Sell	33,225 -1	-0%	-$7	﹤0.01%	3264
2025 Q1	$319K	Hold	33,226	–	–	﹤0.01%	3067
2024 Q4	$360K	Hold	33,226	–	–	﹤0.01%	3042
2024 Q3	$605K	Hold	33,226	–	–	﹤0.01%	2774
2024 Q2	$946K	Sell	33,226 -3	-0%	-$130	﹤0.01%	2541
2024 Q1	$1.69M	Buy	33,229 +3	+0%	+$152	﹤0.01%	2368
2023 Q4	$1.9M	Sell	33,226 -16,612	-33%	-$786K	﹤0.01%	2318
2023 Q3	$203K	Hold	49,838	–	–	﹤0.01%	2886
2023 Q2	$823K	Hold	49,838	–	–	﹤0.01%	2525
2023 Q1	$1.5M	Hold	49,838	–	–	﹤0.01%	2434
2022 Q4	$752K	Hold	49,838	–	–	﹤0.01%	2610
2022 Q3	$1.13M	Hold	49,838	–	–	﹤0.01%	2572
2022 Q2	$1.38M	Hold	49,838	–	–	﹤0.01%	2599
2022 Q1	$2.2M	Hold	49,838	–	–	﹤0.01%	2582
2021 Q4	$3.42M	Hold	49,838	–	–	﹤0.01%	2447
2021 Q3	$9.38M	Hold	49,838	–	–	﹤0.01%	2155
2021 Q2	$7.24M	Buy	+49,838	New	+$11.2M	﹤0.01%	2223
2018 Q4	–	Sell	-1	Closed	-$1K	–	4160
2018 Q3	$1K	Buy	+1	New	+$2.4K	﹤0.01%	3458
2018 Q1	–	Sell	-1,222	Closed	-$5M	–	2736
2017 Q4	$5M	Sell	1,222 -134	-10%	-$562K	﹤0.01%	2171
2017 Q3	$5.63M	Sell	1,356 -459	-25%	-$1.96M	﹤0.01%	2124
2017 Q2	$8.28M	Sell	1,815 -11	-0.6%	-$46.5K	﹤0.01%	2010
2017 Q1	$9.99M	Hold	1,826	–	–	﹤0.01%	1969
2016 Q4	$8.17M	Buy	1,826 +23	+1%	+$287K	﹤0.01%	2039
2016 Q3	$37.8M	Buy	1,803 +35	+2%	+$633K	0.01%	1422
2016 Q2	$26.9M	Buy	1,768 +368	+26%	+$8.41M	﹤0.01%	1540
2016 Q1	$38.9M	Buy	1,400 +1	+0.1%	+$21.1K	0.01%	1360
2015 Q4	$40M	Buy	1,399 +1	+0.1%	+$33K	0.01%	1350
2015 Q3	$34.7M	Buy	1,398 +3	+0.2%	+$202K	﹤0.01%	1407
2015 Q2	$118M	Buy	1,395 +13	+0.9%	+$1.19M	0.02%	961
2015 Q1	$140M	Buy	1,382 +489	+55%	+$65.1M	0.02%	874
2014 Q4	$116M	Buy	893 +252	+39%	+$18.5M	0.02%	937
2014 Q3	$31.1M	Buy	641 +18	+3%	+$631K	﹤0.01%	1534
2014 Q2	$16.7M	Sell	623 -16	-3%	-$377K	﹤0.01%	1883
2014 Q1	$16.7M	Buy	639 +171	+37%	+$4.85M	﹤0.01%	1844
2013 Q4	$12.5M	Hold	468	–	–	﹤0.01%	1894
2013 Q3	$13.6M	Buy	468 +18	+4%	+$639K	﹤0.01%	1845
2013 Q2	$18.1M	Buy	+450	New	+$16.9M	﹤0.01%	1697

Other funds holding TPST

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Fidelity Investments's TPST Position: Q2 2026 in Review

Fidelity Investments sold out of Tempest Therapeutics (TPST) in Q2 2026, closing a stake of 33,225 shares — an estimated $54.5K sold.

Fidelity Investments first reported a position in TPST in Q2 2013 and held it in 40 quarters. The position peaked at $140M in Q1 2015. 21 funds tracked by Wall St. Rank hold TPST as of Q2 2026.

Fidelity Investments reported no remaining Tempest Therapeutics position as of Q2 2026 after selling out during the quarter.
Fidelity Investments sold 33,225 Tempest Therapeutics shares in Q2 2026, an estimated $54.5K.
Fidelity Investments first reported a position in Tempest Therapeutics in Q2 2013 and held it in 40 quarters.
Fidelity Investments's Tempest Therapeutics position peaked at $140M in Q1 2015.
21 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.